BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19806026)

  • 21.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective neuronal targeting in prion disease.
    DeArmond SJ; Sánchez H; Yehiely F; Qiu Y; Ninchak-Casey A; Daggett V; Camerino AP; Cayetano J; Rogers M; Groth D; Torchia M; Tremblay P; Scott MR; Cohen FE; Prusiner SB
    Neuron; 1997 Dec; 19(6):1337-48. PubMed ID: 9427256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of the cellular prion protein (PrPC) in brains of livestock and domesticated species.
    Díaz-San Segundo F; Salguero FJ; de Avila A; Espinosa JC; Torres JM; Brun A
    Acta Neuropathol; 2006 Nov; 112(5):587-95. PubMed ID: 16957924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of bovine spongiform encephalopathy-specific PrP(Sc) by treatment with heat and guanidine thiocyanate.
    Meyer RK; Oesch B; Fatzer R; Zurbriggen A; Vandevelde M
    J Virol; 1999 Nov; 73(11):9386-92. PubMed ID: 10516047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular dendritic cell-specific prion protein (PrP) expression alone is sufficient to sustain prion infection in the spleen.
    McCulloch L; Brown KL; Bradford BM; Hopkins J; Bailey M; Rajewsky K; Manson JC; Mabbott NA
    PLoS Pathog; 2011 Dec; 7(12):e1002402. PubMed ID: 22144895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical characterization of cell types expressing the cellular prion protein in the small intestine of cattle and mice.
    Miyazawa K; Kanaya T; Tanaka S; Takakura I; Watanabe K; Ohwada S; Kitazawa H; Rose MT; Sakaguchi S; Katamine S; Yamaguchi T; Aso H
    Histochem Cell Biol; 2007 Mar; 127(3):291-301. PubMed ID: 17165097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving views in prion glycosylation: functional and pathological implications.
    Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
    Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
    Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different behavior toward bovine spongiform encephalopathy infection of bovine prion protein transgenic mice with one extra repeat octapeptide insert mutation.
    Castilla J; Gutiérrez-Adán A; Brun A; Pintado B; Parra B; Ramírez MA; Salguero FJ; Díaz San Segundo F; Rábano A; Cano MJ; Torres JM
    J Neurosci; 2004 Mar; 24(9):2156-64. PubMed ID: 14999066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neurochemical nature of PrP(c)-containing cells in the rat brain.
    Moleres FJ; Velayos JL
    Brain Res; 2007 Oct; 1174():143-51. PubMed ID: 17854776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prion protein misfolding.
    Kupfer L; Hinrichs W; Groschup MH
    Curr Mol Med; 2009 Sep; 9(7):826-35. PubMed ID: 19860662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of Prion protein (PrP-Sc) and epidemiological study of BSE in Korea.
    Koo HC; Park YH; Lee BC; Chae C; O'Rourke KI; Baszler TV
    J Vet Sci; 2001 Apr; 2(1):25-31. PubMed ID: 14614290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular bases of prion diseases].
    Rać M; Rać M
    Ann Acad Med Stetin; 2006; 52(3):5-13. PubMed ID: 17385343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring prion protein stability by NMR.
    Julien O; Graether SP; Sykes BD
    J Toxicol Environ Health A; 2009; 72(17-18):1069-74. PubMed ID: 19697241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine.
    Albanese V; Lawson VA; Hill AF; Cappai R; Di Guardo G; Staikopoulos V; Thacker M; Furness JB; Chiocchetti R
    Auton Neurosci; 2008 Jun; 140(1-2):17-23. PubMed ID: 18358791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synaptic prion protein immuno-reactivity in the rodent cerebellum.
    Haeberlé AM; Ribaut-Barassin C; Bombarde G; Mariani J; Hunsmann G; Grassi J; Bailly Y
    Microsc Res Tech; 2000 Jul; 50(1):66-75. PubMed ID: 10871550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of cellular prion-related protein by murine Langerhans cells and keratinocytes.
    Sugaya M; Nakamura K; Watanabe T; Asahina A; Yasaka N; Koyama Yi; Kusubata M; Ushiki Y; Kimura K; Morooka A; Irie S; Yokoyama T; Inoue K; Itohara S; Tamaki K
    J Dermatol Sci; 2002 Feb; 28(2):126-34. PubMed ID: 11858951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurodevelopmental expression and localization of the cellular prion protein in the central nervous system of the mouse.
    Benvegnù S; Poggiolini I; Legname G
    J Comp Neurol; 2010 Jun; 518(11):1879-91. PubMed ID: 20394048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.